📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact. (2020)

First Author: Van Rie A

Attributed to: Technology supported systems for rapid impact on TB control funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkz564

PubMed Identifier: 32016320

Publication URI: http://europepmc.org/abstract/MED/32016320

Type: Journal Article/Review

Volume: 75

Parent Publication: The Journal of antimicrobial chemotherapy

Issue: 5

ISSN: 0305-7453